Anebulo Pharmaceuticals(ANEB) - 2025 Q3 - Quarterly Results

WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Date of Report (Date of earliest event reported): May 13, 2025 ANEBULO PHARMACEUTICALS, INC (Exact name of Registrant as Specified in Its Charter) Delaware 001-40388 85-1170950 (State or Other Jurisdiction of Incorporation) Anebulo Pharmaceuticals, Inc. 1017 Ranch Road 620 South, Suite 107 Lakeway, TX 78734 (Address of Principal Executive Offi ...